Clinical trial data entry, batch release checks, and regulatory document routing are the engines of drug development. In many pharma and life sciences organizations, those engines are powered by RPA bots that bind to selectors, XPath, or object IDs. When the vendor updates a user interface, the bot stops. A developer must rebuild it. The process repeats every six to twelve months, creating a maintenance backlog that grows faster than the backlog of new projects. At the same time, SOPs live in Word docs, SharePoint, or PDFs. They are written in plain English, but they are not executable. The bot builders must translate every step into flowcharts and decision trees, adding time and risk. The result is a brittle automation stack and a growing gap between what is possible and what is sustainable.
Why RPA breaks in regulated environments
RPA works well when the UI is stable and the process is deterministic. In pharma, UIs change with each release of a LIMS, EHR, or eCTD repository. Each change breaks the selectors that RPA relies on. A single UI update can require hours of developer time to rebuild or retrain a bot. In large enterprises, multiple systems mean multiple points of failure. Studies of RPA deployments show maintenance costs can reach 30 to 40 percent of total automation spend, and failure rates climb when bots are not regularly updated. In highly regulated environments, a bot that halts on an unexpected state is not just an inconvenience. It can delay batch release, create compliance gaps, or trigger rework. The bot cannot see the screen. It cannot interpret an error message or recover from a failed upload. It halts, and a human must intervene.
What changes with computer use agents
- Survives UI changes
- No brittle selectors
- Recovers from exceptions
- Follows the SOP as written
- Works on legacy and Citrix
Computer use agents see the screen and act like a human, so they survive UI updates, need no brittle selectors, and recover from exceptions instead of halting.
The real advantage: SOPs become executable
An SOP written in plain English is already almost a prompt. A computer use agent can read and follow it directly, without the need for a separate flowchart bot. This matters in regulated industries where SOPs are the source of truth. If a process changes, the SOP is updated and the agent adapts. The agent can click, type, read results, and navigate windows. It works across browsers, desktop applications, and legacy environments like Citrix where traditional RPA struggles. It can recover from an unexpected error message, retry the step, or escalate to a human. This reduces the time between process change and automation availability. It also lowers the documentation burden, because the SOP itself becomes the blueprint.
How to move without the risk
A phased approach helps you build discipline and confidence. Start with a single high-pain process that is currently human-heavy and has frequent UI changes. Examples include batch release checklist routing, regulatory document intake, or clinical data verification. Document the current SOP. Map only the critical steps needed for automation. Build a pilot with a computer use agent, measure time savings, error recovery rate, and compliance risk reduction. Then expand to related processes. At the same time, keep RPA for high-volume, stable backend tasks like invoice processing or payroll reconciliation where RPA continues to make sense. The goal is a hybrid stack where agents handle the long tail and RPA handles the core, predictable tasks. This reduces the risk of a monolithic migration while delivering immediate value.
The way to validated workflows in pharma and life sciences is to stop rebuilding bots every time the UI changes. Start with a process that is already documented in an SOP and let a computer use agent run it. Book a demo with the Coasty team to see how agents can turn your SOPs into durable automation at https://cal.com/coasty/15min .
Want to see this in action?
View Case Studies